When Is Rhogam Given? Timeline

Rhogam is given to pregnant women who are Rh-negative and have not yet developed antibodies to the Rh factor. The injection is typically administered at two specific points: around 28 weeks of pregnancy as a routine preventive dose, and within 72 hours after childbirth if the baby is Rh-positive. It may also be given after miscarriage, abortion, amniocentesis, or other events that could mix the mother’s blood with the baby’s.

What Is Rhogam and Why Does It Matter During Pregnancy?

Rhogam is the brand name for a medication called Rho(D) immune globulin. It contains antibodies that target the Rh factor — a protein found on the surface of red blood cells in most people.

If you are Rh-negative, your blood does not have this protein. If you are Rh-positive, it does. This difference usually only matters in one specific situation: when an Rh-negative mother carries an Rh-positive baby.

During pregnancy, small amounts of the baby’s blood can enter the mother’s bloodstream. This can happen naturally or during certain procedures. When an Rh-negative mother’s immune system detects Rh-positive blood cells, it may treat them as foreign and begin producing antibodies against them.

These antibodies do not usually harm a first pregnancy because the baby is already born or nearly born by the time the mother’s immune response develops. But in a subsequent pregnancy with another Rh-positive baby, those antibodies can cross the placenta and attack the baby’s red blood cells. This condition is called hemolytic disease of the newborn, or HDN. It can cause anemia, jaundice, and in severe cases, heart failure or death.

Rhogam prevents this by stopping the mother’s immune system from producing those antibodies in the first place. It is not a treatment for an existing sensitization — it is a preventive measure.

When Is Rhogam Given During Pregnancy?

The standard schedule for Rhogam during pregnancy involves two routine doses and additional doses after any event that might cause fetal blood to mix with maternal blood.

Routine Dose at 28 Weeks

Most Rh-negative pregnant women receive a dose of Rhogam at around 28 weeks of gestation. This is called the antenatal or prenatal dose. It protects against the small chance that fetal blood cells have already entered the mother’s circulation without a known triggering event. The 28-week timing is based on when the risk of sensitization begins to increase and when the medication can provide protection through the remainder of the pregnancy.

Postpartum Dose Within 72 Hours

After delivery, if the baby is confirmed to be Rh-positive, the mother receives another dose of Rhogam. This dose must be given within 72 hours of birth. The 72-hour window is well established in clinical guidelines. If the baby is Rh-negative, no postpartum dose is needed because there is no Rh factor to trigger an immune response.

Doses After Specific Events

Rhogam may also be given after events that can cause fetal-maternal bleeding at any point during pregnancy. These include:

• Miscarriage or threatened miscarriage
• Ectopic pregnancy
• Induced abortion
• Amniocentesis or chorionic villus sampling
• External cephalic version (turning a breech baby)
• Abdominal trauma
• Bleeding during pregnancy

The dose is typically given within 72 hours of the event, though some guidelines allow up to 28 days. The evidence for effectiveness beyond 72 hours is limited, so the sooner it is given, the better.

How Does Rhogam Work in the Body?

Rhogam works by a mechanism called passive immunization. The injection contains antibodies that bind to any Rh-positive red blood cells that have entered the mother’s bloodstream. Once bound, these cells are cleared from circulation before the mother’s immune system can recognize them as foreign and produce its own antibodies.

This is different from a vaccine. A vaccine teaches your immune system to make its own antibodies. Rhogam provides ready-made antibodies that do their job and then break down over time. The protection is temporary — it does not permanently alter your immune system.

Because the antibodies in Rhogam are eventually cleared, the dose at 28 weeks may not fully cover the period around delivery. That is why a second dose is given after birth if the baby is Rh-positive.

What Happens If Rhogam Is Not Given?

If an Rh-negative mother does not receive Rhogam and her baby is Rh-positive, she may become sensitized. Sensitization means her immune system has produced antibodies against the Rh factor.

Once sensitization occurs, it is permanent. There is no way to reverse it. Future pregnancies with Rh-positive babies would be at risk for hemolytic disease of the newborn.

The severity of HDN can range from mild to life-threatening. Mild cases may only require monitoring and treatment for jaundice. Severe cases may require intrauterine blood transfusions or early delivery. In the most severe cases, HDN can cause stillbirth or death shortly after birth.

Before Rhogam was introduced, HDN was a significant cause of infant death. The widespread use of Rhogam has made severe HDN rare in countries where the medication is routinely available.

Who Needs Rhogam and Who Does Not?

Rhogam is only for people who are Rh-negative and have not already developed Rh antibodies. If you are Rh-positive, you do not need it. If you are already sensitized — meaning you have already produced Rh antibodies — Rhogam will not help because the immune response is already established.

Rh status is determined by a blood test early in pregnancy. If you do not know your Rh status, your healthcare provider can check it with a simple blood draw.

In some cases, a woman may be Rh-negative but the father of the baby is also Rh-negative. If both parents are Rh-negative, the baby will also be Rh-negative, and Rhogam is not needed. However, because paternity cannot always be confirmed, many providers give Rhogam regardless unless the father’s Rh status is known with certainty.

What Are the Side Effects of Rhogam?

Rhogam is generally well tolerated. The most common side effects are mild and temporary. They may include:

• Pain, redness, or swelling at the injection site
• Low-grade fever
• Headache
• Muscle aches
• Feeling tired

Serious allergic reactions are rare but possible. Signs of a severe reaction include difficulty breathing, swelling of the face or throat, and a rapid heartbeat. If these occur, seek emergency medical care immediately.

Rhogam is derived from human plasma. The manufacturing process includes steps to remove or inactivate viruses. According to the CDC, the risk of transmission of bloodborne viruses through Rhogam is extremely low. No cases of HIV or hepatitis transmission from Rhogam have been reported in the United States.

Does Rhogam Have Any Risks or Limitations?

Rhogam is not a perfect solution, but it is highly effective when used correctly. The main limitation is timing. If the dose is given too late — more than 72 hours after a sensitizing event — it may not work. The evidence for effectiveness beyond that window is limited.

Another limitation is that Rhogam does not protect against other blood group incompatibilities. It only targets the Rh factor. Other antibodies, such as anti-Kell or anti-Duffy, can also cause HDN, though these are less common.

Some women may decline Rhogam for personal or religious reasons. In those cases, the risk of sensitization and future HDN remains. It is important to discuss any concerns with a healthcare provider.

How Effective Is Rhogam at Preventing Sensitization?

When given at the recommended times, Rhogam is highly effective at preventing Rh sensitization. Research consistently shows that routine use of Rhogam has dramatically reduced the incidence of HDN.

However, no preventive treatment is 100% effective. A small number of women may still become sensitized despite receiving Rhogam. This can happen if the dose is insufficient, if it is given too late, or if there is a large fetal-maternal hemorrhage that overwhelms the medication. In these cases, additional testing and higher doses may be needed.

If you have a large bleed or a procedure that may cause significant fetal-maternal hemorrhage, your provider may order a test called a Kleihauer-Betke test or flow cytometry to measure how much fetal blood is in your circulation. This helps determine if a higher dose of Rhogam is needed.

What Should You Do If You Miss a Dose?

If you miss a dose of Rhogam, contact your healthcare provider as soon as possible. The 72-hour window after a sensitizing event is important, but it is not an absolute cutoff. Some guidelines suggest that Rhogam may still provide some benefit if given up to 28 days after the event, though the evidence for effectiveness in that window is weaker.

Do not wait. The sooner Rhogam is given, the more likely it is to prevent sensitization.